Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes
Elizabeth Barrett-Connor, Kristine E. Ensrud, Kristine Harper, Timothy M. Mason, Andreas Sashegyi, Kathryn A. Krueger, Pamela W. AndersonТом:
25
Рік:
2003
Мова:
english
DOI:
10.1016/s0149-2918(03)80114-5
Файл:
PDF, 876 KB
english, 2003
File converter
Більше результатів пошуку
More benefits 
